Pembrolizumab (pembro) plus epacadostat or placebo for locally advanced or metastatic urothelial carcinoma (UC) after failure of first-line platinum-containing chemotherapy: KEYNOTE-698/ECHO-303.
暂无分享,去创建一个
David C. Smith | T. Powles | H. Nishiyama | C. Sternberg | J. Bellmunt | D. Petrylak | L. Fong | Lei Pang | M. Munteanu | Yufan Zhao | Mei Chen